Assistant Professor, Medicine
Urologic Oncology Program
UNC Lineberger Bladder Cancer Center of Excellence
Area of Interest
Jeffrey Damrauer, PhD, is an assistant professor in the Department of Medicine and co-leads the Bladder Cancer Research Program, directing the group’s bioinformatics efforts. He has a long and productive track record in bladder cancer research, including the initial discovery and characterization of molecular subtypes of muscle invasive bladder cancer and the identification of a novel gene expression signature that is predictive of response to BCG therapy.
Damrauer’s current interests include using bioinformatics approaches to understand the influence of transcriptomic and genomic events on bladder cancer heterogeneity and how the integration of clinical and genomic data can be used to optimize bladder cancer patients’ response to therapy.
News and Stories
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
Scientists discover key enzyme in breast cancer proliferation, treatment resistance
Basal-like breast cancer is the most aggressive and difficult-to-treat subtype of breast cancer, and it largely overlaps with the triple-negative classification of the disease. Patients are in dire need of improved therapies that attack the underlying cellular features of these types of breast cancer. Now scientists at the University of North Carolina Lineberger Comprehensive Cancer …